The blockade of bulbospinal inhibition by imipramine, desipramine and pargyline.
D000818:Animals; D002415:Cats; D002421:Caudate Nucleus / Q000502:physiology; D003655:Decerebrate State; D003891:Desipramine / Q000494:pharmacology*; D004558:Electric Stimulation; D004567:Electrodes, Implanted; D005260:Female; D010134:Fenclonine / Q000494:pharmacology; D007099:Imipramine / Q000494:pharmacology*; D007796:Laminectomy; D008297:Male; D008526:Medulla Oblongata / Q000187:drug effects*; D008781:Methyltyrosines / Q000494:pharmacology; D008784:Methysergide / Q000494:pharmacology; D009433:Neural Inhibition / Q000187:drug effects*; D010293:Pargyline / Q000494:pharmacology*; D012023:Reflex, Monosynaptic / Q000187:drug effects*; D013116:Spinal Cord / Q000187:drug effects* / Q000502:physiology; D013126:Spinal Nerve Roots / Q000502:physiology; D013238:Stereotaxic Techniques; D013997:Time Factors; D014365:Tryptophan Hydroxylase / Q000037:antagonists & inhibitors; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors
D008781:Methyltyrosines; D010293:Pargyline; D014446:Tyrosine 3-Monooxygenase; D014365:Tryptophan Hydroxylase; D007099:Imipramine; D010134:Fenclonine; D003891:Desipramine; D008784:Methysergide